Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Rating) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 1,535,900 shares, a growth of 5.5% from the March 31st total of 1,455,600 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is currently 7,679.5 days.
Sumitomo Pharma Stock Performance
OTCMKTS:DNPUF opened at $5.90 on Thursday. Sumitomo Pharma has a 12 month low of $5.90 and a 12 month high of $9.69. The stock has a 50 day moving average of $6.30 and a two-hundred day moving average of $6.85.
Analysts Set New Price Targets
Separately, Jefferies Financial Group upgraded Sumitomo Pharma from a “hold” rating to a “buy” rating in a report on Tuesday, April 25th.
Sumitomo Pharma Company Profile
Sumitomo Pharma Co, Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia.
Featured Stories
- Get a free copy of the StockNews.com research report on Sumitomo Pharma (DNPUF)
- Starbucks Stock Becomes a Value Play
- Kraft Heinz Recovery Gains Momentum
- Here’s Why AMD’s Weak Guidance Is A Blessing In Disguise
- BP Shares Sold Off After Earnings: Here Is What Upset Markets
- Will Forced Divesture Of Grail Boost Illumina Shareholder Value?
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
-tbk-logo.png&h=45&w=95&zc=2){kind=logo}
